Back to Search
Start Over
Corrigendum: Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer.
- Source :
-
Frontiers in pharmacology [Front Pharmacol] 2024 Nov 14; Vol. 15, pp. 1447095. Date of Electronic Publication: 2024 Nov 14 (Print Publication: 2024). - Publication Year :
- 2024
-
Abstract
- [This corrects the article DOI: 10.3389/fphar.2023.1288883.].<br /> (Copyright © 2024 Yang, Lan, Li, Wu, Song, Wan, Wang, Li, Ji, Wang, Wu and Lan.)
Details
- Language :
- English
- ISSN :
- 1663-9812
- Volume :
- 15
- Database :
- MEDLINE
- Journal :
- Frontiers in pharmacology
- Accession number :
- 39611177
- Full Text :
- https://doi.org/10.3389/fphar.2024.1447095